Part of the Medical Cell Biology Commons
Inhibition of the PI3K/AKT signaling pathway increases efficacy of doxorubicin and its derivative AD198 in bladder and oral cancers, Dmitriy Smolensky Doctoral Dissertations
PDF
Advanced Search